All GLP-1 and GIP analogues require no dose adjustments in hepatic impairment
However, their dosing schedules differ: Mounjaro has a longer titration period with more dose steps, which may help patients adjust more gradually to the medication
In clinical trials, GLP-1 RAs were shown to significantly lower blood pressure (BP) in addition to HbA1c and body weight (BW), indicating the possibility as anti-hypertensive medication of type 2 DM individuals
If you experience this, please talk to your physician right away, or in cases of a medical or mental health emergency, call 911 or go to the nearest emergency room
Availability depends on regulatory status and research authorization in each region
Office of Dietary Supplements Vitamin B12. NIH Office of Dietary Supplements, U.S